Search Results Search Sort by RelevanceMost Recent Policy Forum Sep 2009 Emerging Dilemmas in Newborn Screening Don B. Bailey, Jr, PhD, Debra Skinner, PhD, Myra I. Roche, MS, CGC, and Cynthia Powell, MD, MS Research questions must be answered to inform policy decisions about the hereditary diseases and conditions for which newborns should be tested. Virtual Mentor. 2009;11(9):709-713. doi: 10.1001/virtualmentor.2009.11.9.pfor2-0909. Medicine and Society Aug 2004 Presymptomatic Genetic Testing for Neurodegenerative Diseases Shane K. Green, PhD Presymptomatic genetic testing for neurodegenerative diseases can help patients make effective treatment decisions, but the medical profession needs to ensure that the increasing use of the tests is done responsibly. Virtual Mentor. 2004;6(8):360-363. doi: 10.1001/virtualmentor.2004.6.8.msoc1-0408. Pagination First page « First Previous page ‹ Previous … Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 Page 10 Page 11 Current page 12
Policy Forum Sep 2009 Emerging Dilemmas in Newborn Screening Don B. Bailey, Jr, PhD, Debra Skinner, PhD, Myra I. Roche, MS, CGC, and Cynthia Powell, MD, MS Research questions must be answered to inform policy decisions about the hereditary diseases and conditions for which newborns should be tested. Virtual Mentor. 2009;11(9):709-713. doi: 10.1001/virtualmentor.2009.11.9.pfor2-0909.
Medicine and Society Aug 2004 Presymptomatic Genetic Testing for Neurodegenerative Diseases Shane K. Green, PhD Presymptomatic genetic testing for neurodegenerative diseases can help patients make effective treatment decisions, but the medical profession needs to ensure that the increasing use of the tests is done responsibly. Virtual Mentor. 2004;6(8):360-363. doi: 10.1001/virtualmentor.2004.6.8.msoc1-0408.